Compare NVAX & UTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | UTI |
|---|---|---|
| Founded | 1987 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1996 | 2003 |
| Metric | NVAX | UTI |
|---|---|---|
| Price | $7.93 | $25.03 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $11.33 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 3.0M | 1.5M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 309.76 | 50.67 |
| EPS | N/A | ★ 0.28 |
| Revenue | ★ $1,123,479,000.00 | $835,616,000.00 |
| Revenue This Year | N/A | $10.15 |
| Revenue Next Year | N/A | $8.32 |
| P/E Ratio | ★ N/A | $93.39 |
| Revenue Growth | ★ 64.69 | 14.05 |
| 52 Week Low | $6.20 | $21.29 |
| 52 Week High | $11.85 | $51.34 |
| Indicator | NVAX | UTI |
|---|---|---|
| Relative Strength Index (RSI) | 45.60 | 29.71 |
| Support Level | $7.70 | $21.29 |
| Resistance Level | $10.10 | $28.62 |
| Average True Range (ATR) | 0.28 | 2.02 |
| MACD | 0.10 | -0.97 |
| Stochastic Oscillator | 67.00 | 1.43 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.